Clinical use of inhaled corticosteroids in asthma
Authors:
- James N. BaraniukJBJames N. Baraniuk
- 1 January 1996
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 97 (1) , 177-182
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Bone mineral density and the risk of fracture in patients receiving long-term inhaled steroid therapy for asthmaJournal of Allergy and Clinical Immunology, 1995
- Effects of Reducing or Discontinuing Inhaled Budesonide in Patients with Mild AsthmaNew England Journal of Medicine, 1994
- Association of ocular cataracts with inhaled and oral steroid therapy during long-term treatment of asthmaJournal of Allergy and Clinical Immunology, 1993
- A comparative study of the effects of an inhaled corticosteroid, budesonide, and a β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: A randomized, double-blind, parallel-group controlled trialJournal of Allergy and Clinical Immunology, 1992
- An Economic Evaluation of Asthma in the United StatesNew England Journal of Medicine, 1992
- Reduction of budesonide after a year of increased use: A randomized controlled trial to evaluate whether improvements in airway responsiveness and clinical asthma are maintainedJournal of Allergy and Clinical Immunology, 1991
- Clinical EconomicsJAMA, 1989
- Inflammatory mechanisms and nocturnal asthmaThe American Journal of Medicine, 1988
- ADVANTAGES OF HIGH-DOSE INHALED BUDESONIDEThe Lancet, 1988
- Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamineJournal of Allergy and Clinical Immunology, 1987